These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 32327350)
1. Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers. Nam Y; Ryu KD; Jang C; Moon YH; Kim M; Ko D; Chung KS; Gandini MA; Lee KT; Zamponi GW; Lee JY Bioorg Med Chem; 2020 Jun; 28(11):115491. PubMed ID: 32327350 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR study of T-type calcium channel blockers. Part II. Choe YJ; Seo HN; Jung SY; Rhim H; Kim J; Choo DJ; Lee JY Arch Pharm (Weinheim); 2008 Oct; 341(10):661-4. PubMed ID: 18816587 [TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers. Jang SJ; Choi HW; Choi DL; Cho S; Rim HK; Choi HE; Kim KS; Huang M; Rhim H; Lee KT; Lee JY Bioorg Med Chem Lett; 2013 Dec; 23(24):6656-62. PubMed ID: 24220170 [TBL] [Abstract][Full Text] [Related]
4. Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide. El-Wakil MH; Teleb M; Abu-Serie MM; Huang S; Zamponi GW; Fahmy H Bioorg Chem; 2021 Oct; 115():105262. PubMed ID: 34411980 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR studies of a novel series of T-type calcium channel blockers. Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of fluoro-substituted 3,4-dihydroquinazoline derivatives for cytotoxic and analgesic effects. Kim JH; Jeong HR; Jung DW; Yoon HB; Kim SY; Kim HJ; Lee KT; Gadotti VM; Huang J; Zhang FX; Zamponi GW; Lee JY Bioorg Med Chem; 2017 Sep; 25(17):4656-4664. PubMed ID: 28720332 [TBL] [Abstract][Full Text] [Related]
7. 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers. Lee YS; Lee BH; Park SJ; Kang SB; Rhim H; Park JY; Lee JH; Jeong SW; Lee JY Bioorg Med Chem Lett; 2004 Jul; 14(13):3379-84. PubMed ID: 15177437 [TBL] [Abstract][Full Text] [Related]
8. Discovery of potent T-type calcium channel blocker. Seo HN; Choi JY; Choe YJ; Kim Y; Rhim H; Lee SH; Kim J; Joo DJ; Lee JY Bioorg Med Chem Lett; 2007 Nov; 17(21):5740-3. PubMed ID: 17869104 [TBL] [Abstract][Full Text] [Related]
9. T-type Ca2+ channel blockers suppress the growth of human cancer cells. Heo JH; Seo HN; Choe YJ; Kim S; Oh CR; Kim YD; Rhim H; Choo DJ; Kim J; Lee JY Bioorg Med Chem Lett; 2008 Jul; 18(14):3899-901. PubMed ID: 18585035 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers. Rhim H; Lee YS; Park SJ; Chung BY; Lee JY Bioorg Med Chem Lett; 2005 Jan; 15(2):283-6. PubMed ID: 15603940 [TBL] [Abstract][Full Text] [Related]
11. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives. Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033 [TBL] [Abstract][Full Text] [Related]
12. In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells. Byun JS; Sohn JM; Leem DG; Park B; Nam JH; Shin DH; Shin JS; Kim HJ; Lee KT; Lee JY Bioorg Med Chem Lett; 2016 Feb; 26(3):1073-1079. PubMed ID: 26739776 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel T-type calcium channel blockers. Choi JY; Seo HN; Lee MJ; Park SJ; Park SJ; Jeon JY; Kang JH; Pae AN; Rhim H; Lee JY Bioorg Med Chem Lett; 2007 Jan; 17(2):471-5. PubMed ID: 17064894 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist. Choi DL; Jang SJ; Cho S; Choi HE; Rim HK; Lee KT; Lee JY Bioorg Med Chem Lett; 2014 Mar; 24(6):1565-70. PubMed ID: 24529871 [TBL] [Abstract][Full Text] [Related]
15. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA). Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers. Lee JY; Park SJ; Park SJ; Lee MJ; Rhim H; Seo SH; Kim KS Bioorg Med Chem Lett; 2006 Oct; 16(19):5014-7. PubMed ID: 16876410 [TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor. Kang HB; Rim HK; Park JY; Choi HW; Choi DL; Seo JH; Chung KS; Huh G; Kim J; Choo DJ; Lee KT; Lee JY Bioorg Med Chem Lett; 2012 Jan; 22(2):1198-201. PubMed ID: 22177784 [TBL] [Abstract][Full Text] [Related]
18. Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors. Hou W; Ren Y; Zhang Z; Sun H; Ma Y; Yan B Bioorg Med Chem; 2018 May; 26(8):1740-1750. PubMed ID: 29523467 [TBL] [Abstract][Full Text] [Related]
19. New derivatives of quinazoline and 1, 2-dihydroquinazoline n3-oxide with expected antitumor activity. Mikiciuk-Olasik E; Baszczak-Swiatkiewiz K; Zurek E; Krajewska U; Rózalski M; Kruszyński R; Bartczak TJ Arch Pharm (Weinheim); 2004 May; 337(5):239-46. PubMed ID: 15095417 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers. Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]